Skip to main content
Category

Uncategorized

Methods Development for Obtaining Comprehensive Genomic Information from Human Specimens that are Easy to Collect and Store (R43/R44) – Mar 25, 2016

By Uncategorized

Funding Opportunity Number: PAR-13-203
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
CFDA Number: 93.172
93.865
Eligible Applicants Small businesses
Agency Name: HHS-NIH11
Closing Date: Mar 25, 2016
Award Ceiling:
Expected Number of Awards:
Creation Date: Apr 19, 2013
Funding Opportunity Description: This FOA invites applications to develop sensitive technologies or methods for obtaining high quality and comprehensive nucleic acids-based genomic data from limited quantities of human specimens that are easy to collect, handle, and store. Applications that address all of the steps from the collection of specimens, through storage and nucleic acids extraction, to obtaining genomic data will be considered as having highest priority to this FOA. The ease of proposed sample collection methods should be at least comparable to that of the current dried blood spot collection method. The developed technologies or methods should be applicable to clinical point-of-care testing in terms of speed and ease, and ultimately have the potential to be scalable to high throughput settings, while maintaining cost effectiveness. The genomic data obtained must be at least equivalent to that which can be obtained from fresh whole blood in terms of quality and comprehensiveness. It is expected that the research conducted under this FOA will enhance the availability of comprehensive nucleic acids-based genomic data for various clinical and research applications in need of obtaining genomic data from easy-to-collect and handle human specimens.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=231054

Read More

Enhancing post-market surveillance through developing registries for medical device epidemiology (U01) – Apr 30, 2017

By Uncategorized

Funding Opportunity Number: PAR-13-202
Opportunity Category: Discretionary
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Health
CFDA Number: 93.103
Eligible Applicants State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name: HHS-FDA
Closing Date: Apr 30, 2017
Award Ceiling: $150,000
Expected Number of Awards: 2
Creation Date: Apr 19, 2013
Funding Opportunity Description: (1) To address identified gaps in the current postmarket surveillance system by developing new methodologies for registry data collection and linkage, or by adapting known methodologies to medical devices, and (2) To develop novel methodology that allows for use of the registry data collection infrastructure to serve multiple purposes including postmarket surveillance, device tracking through Unique Device Identifiers (UDI), prospective embedded studies, quality improvement, and other uses, and (3) To develop registries and consortia in key medical device areas to implement new registry methodologies that strategically broaden the scope of the US and international postmarket surveillance system.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=231113

Read More

BHI Supports UMD Inventors

By Uncategorized

As part of the University of Maryland’s 26th Annual Invention of the Year Awards ceremony held at the University of Maryland Golf Course on April 16, BioHealth Innovation sweetened the pot for this year’s three award winners. BHI offered each award winner strategic consulting services on federal grants or SBIR awards – valued at $2,500 per company. The BHI Commercial Relevance Program is designed to support small businesses in commercializing their technological research efforts.

The three winning inventions were:
INFORMATION SCIENCE CATEGORY:
Winner:
Time-Reversal Division Multiple Access for Wireless Broadband Communications
Feng Han, Yu-Han Yang, Beibei Wang, Yongle Wu and K. J. Ray Liu

LIFE SCIENCE CATEGORY:
Winner:
A Method for Early Diagnosis of Amyotrophic Lateral Sclerosis (ALS)
Eva Chin and Dapeng Chen

PHYSICAL SCIENCE CATEGORY:
Winner:
A Method for Rapid, Inexpensive Prototyping of Microfluidic Devices
Omid Rahmanian, Donald DeVoe

More Information

biotech-success

Montgomery County and BHI at BIO 2013, Booth 1423

By Uncategorized

biotech-success

The Montgomery County Department of Economic Development and our partner, BioHealth Innovation, Inc., invite you to visit us at Booth 1423, the Maryland Pavilion, during the BIO International Convention in Chicago, April 22 – 25.

Nearly 50 Montgomery County biotech companies, organizations, or public sector entities will attend. Twenty-six Maryland organizations, companies or public-sector entities will be represented in the Maryland Pavilion, Booth 1423, including the following from Montgomery County:

Read More
umd-a-james-clark-engineering

Clark School Faculty Recognized at UMD Invention of the Year Awards

By Uncategorized

umd-a-james-clark-engineering

Time-reversal techniques for optimizing broadband communication networks and rapid prototyping of microfluidics devices were among the Clark School of Engineering inventions recognized as the most promising new technologies at the University of Maryland Invention of the Year Awards.

The University of Maryland’s Office of Technology Commercialization (OTC) hosted the 26th Annual Invention of the Year Awards reception on Tuesday, April 16, 2013 from 4:30-6:00 pm at the University of Maryland Golf Course Club House.

Read More
Malone

Serial Entrepreneur Ken Malone Named BHI Entrepreneur-in-Residence to Offer Commercialization Guidance to Start-Ups Based on UM Discoveries

By Uncategorized

MaloneBioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, today announced its selection of Ken Malone, Ph.D., of Early Charm Ventures, as the first BHI Entrepreneur-in-Residence (EIR) assigned to work directly with UM Ventures. Dr. Malone, a serial entrepreneur who has founded or been an officer of five biotechnology or advanced materials companies, will help advance the commercialization efforts of new start-up companies based upon innovative discoveries coming out of research programs at the University of Maryland (UMD) College Park and Baltimore.

“We’re thrilled to name Ken Malone as an EIR,” said Richard Bendis, BHI President & CEO. “Ken and I have a long history of working together, so I know first hand that he has the experience, drive and perspective to be a true asset to BHI and to the many start-ups he’ll serve from University of Maryland in support of the newly launched UM Ventures initiative.” Dr. Malone will assist any interested UM start-ups once they have been launched.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.